Intracellular expression of single-chain variable fragments to inhibit early stages of the viral life cycle by targeting human immunodeficiency virus type 1 integrase

Journal of Virology

Volumn 70, Issue 12, 1996, Pages 8821-8832

  Levy Mintz, Pnina ^a   Duan, Lingxun ^a   Zhang, Huizhong ^a   Hu, Baocheng ^a   Dornadula, Geethanjali ^a   Zhu, Minghua ^a   Kulkosky, Joseph ^a   Bizub Bender, Diane ^b   Skalka, Anna Marie ^b   Pomerantz, Roger J ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED DNA; INTEGRASE; MONOCLONAL ANTIBODY; VIRUS ENZYME;

ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; CONTROLLED STUDY; DRUG TARGETING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; RETROVIRUS; T LYMPHOCYTE; VIRUS CELL INTERACTION; VIRUS GENE; VIRUS REPLICATION;

EID: 10344256143     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.12.8821-8832.1996     Document Type: Article

References (73)

1. Abbott, M. A., B. J. Poiesz, B. C. Byrne, S. Kwok, J. J. Sninsky, and G. D. Ehrlich. 1988. Enzymatic gene amplification: qualitative and quantitative methods for detecting proviral DNA amplified in vitro. J. Infect. Dis. 158: 1158-1168.
2. Adachi, A., H. E. Gendelman, S. Koenig, T. Folks, R. Willey, A. Kabson, and M. A. Martin. 1986. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59:284-291.
3. Andrake, M. D., and A. M. Skalka. 1995. Multimerization determinants reside in both the catalytic core and C-terminus of avian sarcoma virus integrase. J. Biol. Chem. 270:29299-29306.
4. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Siedman, J. A. Smith, and K. S. Struhl (ed.). 1994. Current protocols in molecular biology, vol. 1. John Wiley & Sons, Inc., New York.
5. Batra, J. K., D. FitzGerald, M. Gately, V. K. Chaudhary, and I. Pastan. 1990. Anti-Tac (Fv)-PE40, a single chain antibody Pseudomonas fusion protein directed at interleukin 2 receptor bearing cells. J. Biol. Chem. 265:15198-15202.
6. Bender, D. B., J. Kulkosky, and A. M. Skalka. 1994. Monoclonal antibodies against HIV type 1 integrase: clues to molecular structure. AIDS Res. Hum. Retroviruses 10:1105-1115.
7. Biocca, S., F. Ruberli, M. Tafani, P. Pierandrei-Amladi, and A. Cattaneo. 1995. Redox state of single chain Fv fragments targeted to the endoplasmic reticulum, cytosol and mitochondria. BioTechniques 13:1110-1115.
8. Bizub-Bender, D., and A. Skalka. Unpublished observations.
9. Brown, P. O., B. Bowerman, H. E. Varmus, and J. M. Bishop. 1987. Correct integration of retroviral DNA in vitro. Cell 49:347-356.
10. Bujaca, G., M. Jaskolski, J. Alexandratos, A. Wlodawer, G. Merkel, R. A. Katz, and A. M. Skalka. 1995. High resolution structure of the catalytic domain of avian sarcoma virus integrase. J. Mol. Biol. 253:333-346.
11. Bukrinsky, M., N. Sharova, and M. Stevenson. 1993. Human immunodeficiency virus type 1 2-LTR circles reside in a nucleoprotein complex which is different from the preintegration complex. J. Virol. 67:6863-6865.
12. Cannon, P. M., E. D. Byles, S. M. Kingsman, and A. J. Kingsman. 1996. Conserved sequences in the carboxyl terminus of integrase that are essential for human immunodeficiency virus type 1 replication. J. Virol. 70:651-657.
13. Carteau, S., J. F. Mouscadet, H. Goulaouic, F. Subra, and C. Auclair. 1993. Effect of topoisomerase inhibitor on the vitro HIV DNA integration reaction. Biochem. Biophys. Res. Commun. 192:1409-1414.
14. Carteau, S., J. F. Mouscadet, H. Goulaouic, F. Subra, and C. Auclair. 1993. Inhibitory effect of the polyanionic drug suramin on the in vitro HIV DNA integration reaction. Arch. Biochem. Biophys. 305:606-610.
15. Chen, I. S.-Y., J. Bagley, and W. A. Marasco. 1994. Intracellular antibodies as a new class of therapeutic molecules for gene therapy. Hum. Gene Ther. 5:595-601.
16. Chen, I. S.-Y., Y. Khouri, J. Bagley, and W. A. Marasco. 1994. Combined intra- and extracellular immunization against human immunodeficiency virus type 1 infection with a human anti-gp120 antibody. Proc. Natl. Acad. Sci. USA 91:5932-5936.
17. Craigie, R., T. Fujiwara, and F. Bushman. 1990. The IN protein of Moloney murine leukemia virus processes the viral DNA ends and accomplishes their integration in vitro. Cell 62:829-837.
18. Cullen, B. R. 1991. Human immunodeficiency virus as a prototypic complex retrovirus. J. Virol. 65:1053-1056.
19. Dropulic, B., and K.-T. Jeang. 1994. Gene therapy for human immunodeficiency virus infection: genetic antiviral strategies and targets for intervention. Hum. Gene Ther. 5:927-939.
20. Duan, L.-X., O. Bagasra, M. A. Laughlin, J. W. Oakes, and R. J. Pomerantz. 1994. Potent inhibition of human immunodeficiency virus type 1 replication by an intracellular anti-Rev single-chain antibody. Proc. Natl. Acad. Sci. USA 91:5075-5079.
21. Duan, L.-X., and R. J. Pomerantz. 1994. Elimination of endogenous aberrant kappa chain transcription from sp2/0-derived hybridoma cells by specific ribozyme cleavage: utility in genetic therapy of HIV-1 infections. Nucleic Acids Res. 22:5433-5438.
22. Duan, L.-X., and R. J. Pomerantz. 1996. Intracellular antibodies for HIV-1 gene therapy. Sci. Med. 3:24-33.
23. Duan, L.-X., H. Zhang, J. W. Oakes, O. Bagasra, and R. J. Pomerantz. 1994. Molecular and virological effects of intracellular anti-Rev single-chain variable fragments on the expression of various human immunodeficiency virus-1 strains. Hum. Gene Ther. 5:1315-1324.
24. Duan, L.-X., M. Zhu, O. Bagasra, and R. J. Pomerantz. 1995. Intracellular immunization against HIV-1 infection of human T-lymphocytes: utility of anti-Rev single-chain variable fragments. Hum. Gene Ther. 6:1561-1571.
25. Dyda, F., A. B. Hickman, T. M. Jenkins, A. Engelman. R. Craigie, and D. R. Davies. 1994. Crystal structure of the catalytic domain of HIV-1 integrase: similarity to other polynucleotidyl transferases. Science 266:1981-1986.
26. Elison, V., H. Abrams, T. Roe, J. Lifson, and P. Brown. 1990. Human immunodeficiency virus integration in a cell-free system. J. Virol. 64:2711-2715.
27. Engelman, A., G. Englund, J. M. Orenstein, M. A. Martin, and R. Craigie. 1995. Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication. J. Virol. 69:2729-2736.
28. Engelman, A., A. B. Hickman, and R. Craigie. 1994. The core and carboxyl-terminal domains of the integrase protein of human immunodeficiency virus type 1 each contribute to nonspecific DNA binding. J. Virol. 68:5911-5917.
29. Engelman, A., K. Mizuuch, and R. Craigie. 1991. HIV-1 DNA integration: mechanism of viral DNA cleavage and DNA strand transfer. Cell 67:1211-1221.
30. Erice, A., and H. H. Balfour. 1994. Resistance of HIV-1 to anti-retroviral agents: a review. Clin. Infect. Dis, 18:149-156.
31. Farnet, C. M., and W. A. Haseltine. 1991. Determination of viral proteins present in the human immunodeficiency virus type 1 preintegration complex. J. Virol. 65:1910-1915.
32. Feldherr, C. M., and D. Akin. 1994. Role of nuclear trafficking in regulating cellular activity. Int. Rev. Cytol. 151:183-228.
33. Gallay, P., S. Swingler, J. Song, F. Bushman, and D. Trono. 1995. HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase. Cell 83:569-576.
34. Hirsch, M. S., and R. T. D'Aquila. 1993. Therapy for human immunodeficiency virus infection. N. Engl. J. Med. 328:1686-1695.
35. Holler, T. P., S. K. Foltin, Q.-Z. Ye, and D. J. Hupe. 1993. HIV-1 integrase expressed in E. coli from a synthetic gene. Gene 136:323-328.
36. Jenkins, T. M., A. Engelman, R. Ghirlando, and R. Craigie. 1996. A soluble active mutant of HIV-1 integrase. J. Biol. Chem. 271:7712-7713.
37. Katz, R. A., G. Merkel, J. Kulkosky, J. Leis, and A. M. Skalka. 1990. The avian retroviral IN protein is both necessary and sufficient for integrative recombination in vitro. Cell 63:87-95.
38. Katz, R. A., and A. M. Skalka. 1994. The retroviral enzymes. Annu. Rev. Biochem. 63:133-173.
39. Kubota, S., L. Duan, R. A. Furuta, M. Hatanaka, and R. J. Pomerantz. 1996. Nuclear preservation and cytoplasmic degradation of human immunodeficiency virus type 1 Rev protein. J. Virol. 70:1282-1287.
40. Kulkosky, J., K. S. Jones, R. A. Katz, J. P. G. Mack, and A. M. Skalka. 1992. Residues critical for retroviral integrative recombination in a region that is highly conserved among retroviral/retrotransposon integrases and bacterial insertion sequence transposases. Mol. Cell. Biol. 12:2331-2338.
41. Kulkosky, J., R. A. Kalz, and A. M. Skalka. 1990. Terminal nucleotides of the preintegrative linear form of HIV-1 DNA deduced from the sequence of circular DNA junctions. J. Acquired Immune Defic. Syndr. 3:852-858.
42. Kulkosky, J., and A. M. Skalka. 1994. Molecular mechanism of retroviral DNA integration. Pharmacol. Ther. 61:185-203.
43. Kwok, S., J. J. Lipka, N. McKinney, D. E. Kellog, B. J. Poiesz, S. K. H. Foung, and J. J. Sninsky. 1990. Low incidence of HTLV infections in random blood donors with indeterminate Western blot patterns. Transfusion 30:491-494.
44. Levy, J. A. 1993. Pathogenesis of human immunodeficiency virus infection. Microbiol. Rev. 57:183-289.
45. Levy-Mintz, P., L.-X. Duan, D. Bizuh-Bender, J. Kulkosky, A. M. Skalka, and R. J. Pomerantz. 1995. Anti-HIV-1 integrase single chain variable fragments (SFv) as tools for gene therapy. Presented at the Cold Spring Harbor Symposium on RNA Tumor Viruses, Cold Spring Harbor, N.Y., 26 May 1995.
46. Lisziewicz, J., D. Sun, D. Lisziewicz, and R. C. Gallo. 1995. Anti-tat gene therapy: a candidate for late-stage AIDS patients. Gene Ther. 2:218-222.
47. Liu, J., C. Woffendin, Z.-Y. Yang, and G. J. Nabel. 1994. Regulated expression of a dominant negative form of Rev improves resistance to HIV replication in T cells. Gene Ther. 1:32-37.
48. Lutzke, P., R. A. C. Vink, and R. H. A. Plasterk. 1994. Characterization of the minimal DNA-binding domains of the HIV integrase protein. Nucleic Acids Res. 22:4125-4131.
49. Maciejewski, J. P., F. F. Weichold, N. S. Young, A. Cara, D. Zella, M. S. Reitz, Jr., and R. C. Gallo. 1995. Intracellular expression of antibody fragments directed against HIV reverse transcriptase prevents HIV infection in vitro. Nat. Med. 1:667-673.
50. Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
51. Marasco, W. A., W. A. Haseltine, and I. S.-Y. Chen. 1993. Design, intracellular expression, and activity of a human anti-human immunodeficiency virus type 1 gp120 single-chain antibody. Proc. Natl. Acad. Sci. USA 90:7889-7893.
52. Marchuk, D., M. Drumm, A. Saulino, and F. S. Collins. 1990. Construction of T-vectors, a rapid and general system for direct cloning of unmodified PCR products. Nucleic Acids Res. 19:1154.
53. Masuda, T., V. Planelles, P. Krogstad, and I. S. Y. Chen. 1995. Genetic analysis of human immunodeficiency virus type 1 integrase and the U3 att site: unusual phenotype of mutants in the zinc finger-like domain. J. Virol. 69:6687-6696.
54. Mazumder, A., D. Cooney, R. Agbaria, M. Gupta, and Y. Pommier. 1994. Inhibition of human immunodeficiency virus type 1 integrase by 3′-azido-3′-deoxythymidylate. Proc. Natl. Acad. Sci. USA 91:5771-5775.
55. Mhashilkar, A. B., J. Bagley, I. S.-Y. Chen, A. M. Szilvay, D. G. Heiland, and W. A. Marasco. 1995. Inhibition of HIV-1 Tat-mediated LTR transaclivation und HIV-1 infection by anti-Tat single chain antibodies. EMBO J. 14:1542-1551.
56. Miller, A. D., and G. J. Roseman. 1989. Improved retroviral vectors for gene transfer and expression. BioTechniques 7:980-990.
57. Pauza, C. D., and J. Galindo. 1989. Persistent human immunodeficiency virus type 1 infection of monoblastoid cells leads to accumulation of self-integrated viral DNA and to production of defective virions. J. Virol. 63: 3700-3707.
58. Pauza, C. D., P. Trivedi, T. S. Mckechnie, D. D. Richman, and F. M. Graziano. 1994. 2-LTR circular viral DNA as a marker for human immunodeficiency virus type 1 infection in vivo. Virology 205:470-478.
59. Pilkington, G. R., L.-X. Duan, M. H. Zhu, W. Kell, and R. J. Pomerantz. 1996. Recombinant human Fab antibody fragments to HIV-1 Rev and Tat regulatory proteins: direct selection from a phage library. Mol. Immunol. 33:439-449.
60. Poiesz, B. J., G. D. Ehrlich, B. C. Byrne, K. Wells, S. Kwok, and J. Sninsky. 1990. In L. M. de la Maza and E. M. Peterson (ed.), Medical virology, vol. 9. p. 47-75. Plenum Press, New York.
61. Pomerantz, R. J., and D. Trono. 1995. Genetic therapies for HIV infections: promise for the future. AIDS 9:985-993.
62. Pryciak, P. M., and H. E. Varmus. 1992. Nucleosomes, DNA-binding proteins, and DNA sequence modulate retroviral integration target site selection. Cell 69:769-780.
63. Scharfmann, R., J. H. Axelrod, and I. M. Verma. 1991. Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants. Proc. Natl. Acad. Sci. USA 88:4626-4630.
64. Shaheen, F., L. Duan, M. Zhu, O. Bagasra, and R. J. Pomerantz. 1996. Targeting human immunodeficiency virus type 1 reverse transcriptase by intracellular expression of single-chain variable fragments to inhibit early stages of the viral life cycle. J. Virol. 70:3392-3400.
65. Sherman, P. A., M. L. Dickson, and J. A. Fyfe. 1992. Human immunodeficiency virus type 1 integration protein: DNA sequence requirements for cleaving and joining reactions. J. Virol. 66:3593-3601.
66. Siomi, H., H. Shida, M. Maki, and M. Hatanaka. 1990. Effects of a highly basic region of human immunodeficiency virus Tat protein on nucleolar localization. J. Virol. 64:1803-1807.
67. St. Clair, M. H., J. L. Martin, G. Tudor-Williams, M. C. Bach, C. L. Vavro, D. M. King, P. Kellam, S. D. Kemp, and B. A. Larder. 1991. Resistance to ddl and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase. Science 253:1557-1559.
68. Studier, F. W., A. H. Rosenberg, J. J. Dunn, and J. W. Dubendorff. 1990. Use of T7 polymerase for direct expression of cloned genes. Methods Enzymol. 185:60-89.
69. Sun, L. Q., J. Pyati, J. Smythe, L. Wang, J. MacPherson, W. Gerlach, and G. Symonds. 1995. Resistance to human immunodeficiency virus type 1 infection conferred by transduction of human peripheral blood lymphocytes with ribozyme, antisense, or polymeric trans-activation response element constructs. Proc. Natl. Acad. Sci. USA 92:7272-7276.
70. Tai, M.-S., M. Mudgett-Hunter, D. Levinson, G.-M. Wu, E. Haber, H. Oppermann, and J. S. Huston. 1990. A bifunctional fusion protein containing Fc-hinding fragment B of staphylococcal protein A amino terminal to anti-digoxin single-chain Fv. Biochemistry 29:8024-8030.
71. Wu, Y., L. Duan, M. Zhu, B. Hu, S. Kubota, O. Bagasra, and R. J. Pomerantz. 1996. Binding of intracellular anti-Rev single chain variable fragments to different epitopes of human immunodeficiency virus type 1 Rev: variations in viral inhibition. J. Virol. 70:3290-3297.
72. Yu, M., J. Ojwang, O. Yamada, A. Hampel, J. Rapapport, D. Looney, and F. Wong-Staal. 1993. A hairpin ribozyme inhibits expression of diverse strains of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 90: 6340-6344.
73. Zhang, H., Y. Zhang, T. P. Spicer, M. A. Abbott, and B. J. Poiesz. 1993. Reverse transcription takes place within extracellular HIV-1 virions: potential biological significance. AIDS Res. Hum. Retroviruses 9:1287-1296.